Russian National Health Telephone Survey (RNHTS)
Launched by I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY · Jun 9, 2023
Trial Information
Current as of May 14, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The Russian National Health Telephone Survey (RNHTS) is a study aimed at understanding the health and well-being of adults in Russia. Researchers want to learn about how people feel about their health, their health-related habits, and how often they use healthcare services. To gather this information, they will conduct phone interviews with a variety of adult participants across the country.
To be eligible for this survey, individuals must be 18 years or older and able to give permission for their participation over the phone. Unfortunately, those who are very ill, have serious cognitive issues, or struggle with hearing or speaking may not be able to join. If you participate, you can expect a friendly phone call where you’ll answer questions about your health and lifestyle. This study is currently active but not recruiting new participants. Your responses can help improve public health efforts in Russia!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Respondents are aged 18 and above.
- • Respondents provide informed consent via telephone at the beginning of the survey.
- Exclusion Criteria:
- • Respondents refuse to provide informed consent.
- • Respondents are severely ill or too frail to participate.
- • Respondents have cognitive problems.
- • Respondents have hearing or speaking problems.
About I.M. Sechenov First Moscow State Medical University
i.m. Sechenov First Moscow State Medical University is a prestigious institution dedicated to advancing medical education, research, and clinical practice. As a leading center for medical innovation in Russia, the university fosters a collaborative environment for scientific inquiry and the development of novel therapies. With a commitment to high-quality clinical trials, i.m. Sechenov aims to contribute significantly to the global biomedical landscape by evaluating new treatments and improving patient care through rigorous research methodologies and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moscow, , Russian Federation
Patients applied
Trial Officials
Ekaterina Aleksandrova
Principal Investigator
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported